Forbo Holding AG (FORN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 856.00 |
|---|---|
| 52-week range | 669.00 – 990.00 |
| Return, 1 month / 3 months | −9.8% / +11.0% |
| Return, 1 year / 3 years | +16.3% / −6.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 32 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -28.4% |
| Average daily value traded | 2.69M CHF |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Forbo Holding is a Swiss manufacturer of flooring, adhesives and belting products. Its flooring business supplies linoleum, vinyl and other resilient floor coverings for commercial, public and residential buildings, while its adhesives are used in construction and industrial assembly. The company also makes conveyor and processing belts for sectors such as food processing, logistics and manufacturing. Forbo is based in Switzerland and serves customers in many countries through its own brands and distribution networks.
Forbo Holding AG trades under the code FORN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Forbo Holding AG (FORN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 856.00 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 76 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.3% and over the last three months it rose 11.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.7% | ||
| From 52-week high | -13.5% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.0% | ||
| 6-month return | 18.4% | ||
| 12-month return, skipping the last month | 29.0% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.4% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.69M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −8.5% |
|---|---|
| 1 month | −9.8% |
| 3 months | +11.0% |
| 6 months | +18.4% |
| 1 year | +16.3% |
| 3 years | −6.8% |
| 5 years | −46.9% |
Signals
| 50-day / 200-day average | 937.28 / 825.76 |
|---|---|
| Golden / death cross (60 days) | Golden, 53 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 28.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Apr 2026 | CHF 25.0000 |
| 9 Apr 2025 | CHF 25.0000 |
| 10 Apr 2024 | CHF 25.0000 |
| 4 Apr 2023 | CHF 23.0000 |
| 6 Apr 2022 | CHF 25.0000 |
| 8 Apr 2021 | CHF 20.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.